Professional and Reliable IHC Raw Antibody Solutions for Hemopathology
Hemopathology frequently involves complex cellular lineage identification and clonality analysis. AREX provides high-quality IHC raw antibodies supporting detection of lymphoid, myeloid, stem cell markers, and other relevant targets to optimize diagnostic, subtyping, and prognostic assessment solutions for leukemia, lymphoma, and myeloproliferative disorders.
Core Advantages:
High specificity and low background suited to the complex cellular staining environment of bone marrow and hematopoietic tissue
Good sensitivity meeting needs across different cell types and disease stages
Excellent batch-to-batch consistency for large-scale supply
AREX hemopathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.